Transplant News and Research

RSS

Contradiction surrounds face transplant patient

Controversy continues to grow around the world's first face transplant in France.

6 Dec 2005

Face transplant woman doing well

French surgeons say that the 38-year-old recipient of the world's first partial face transplant regained consciousness 24 hours after her operation and is doing well.

5 Dec 2005

Heart pump technology - comparative study

Chicago's first participant in the RELIANT (Randomized Evaluation of the Novacor(r) LVAS In A Non-Transplant Population) research study recently went home from Northwestern Memorial Hospital.

5 Dec 2005

Liver transplants may not be suitable for all cystic fibrosis patients

A new study on patients with cystic fibrosis (CF) who have had abnormal bleeding from ruptured blood vessels in the esophagus (variceal hemorrhage) as a result of liver disease found that transplant may not be indicated if there are no other indications of advanced liver disease.

5 Dec 2005

Mycophenolate mofetil helps treat lupus patients

Treating lupus patients suffering from kidney inflammation with a medicine known as mycophenolate mofetil may be more effective in inducing remission than treating them with the standard regimen of intravenous cyclophosphamide (Cytoxan), a new clinical trial indicates.

2 Dec 2005

French woman has worlds' first face transplant

The operation apparently lasted several hours where tissues, muscles, arteries and veins were taken from a brain-dead donor and attached to the patient's lower face.

30 Nov 2005

Coaxing human embryonic stem cells to make dopamine

For all of the promise embryonic stem cells hold for therapies for neurodegenerative diseases such as Parkinson's disease, they are notoriously difficult to use.

28 Nov 2005

Left ventricular assistant devices extend lives of patients too sick for transplant

Pumps implanted into the chest to maintain circulation can significantly extend the lives of the sickest patients in end-stage heart failure who are not candidates for heart transplantation, according to the results of a clinical trial led by Duke University Medical Center cardiologists.

28 Nov 2005

New drug CellCept far more effective in treating kidney problems in lupus patients

A new study has shown that the drug CellCept is just as good at fighting kidney complications from the debilitating disease lupus with far fewer side effects than standard treatment using the cancer drug Cytoxan.

24 Nov 2005

Sperm stem cells research provides exciting findings

New experiments that prevented rat sperm stem cells from changing permanently into sperm have brought researchers one step closer to coaxing such cells to behave like embryonic stem cells, capable of growing into many other types of cells in the body.

20 Nov 2005

Scientists direct embryonic stem cells to become cartilage cells

Scientists from Imperial College London have successfully converted human embryonic stem cells into cartilage cells, offering encouragement that replacement cartilage could one day be grown for transplantation.

20 Nov 2005

Stem cells to repair heart tissue soon after a heart attack

Stem cells derived from human heart tissue develop into multicellular, spherical structures called cardiospheres that express the normal properties of primitive heart tissue, smooth muscle and blood vessel cells, according to a study by Johns Hopkins researchers.

20 Nov 2005

Scientists use stem cells to grow cartilage

16 Nov 2005

World first trial grows blood vessels from patient's own skin

A team of American scientists have successfully implanted blood vessels grown entirely from a patient's own cells.

16 Nov 2005

Hospital liver transplant program suspended after 32 die waiting

Following reports in the media that a Southern California hospital had suspended its liver transplant program and had turned down scores of donor organs while 32 patients awaiting transplants had died, the facility has had it's certification of the liver transplant program revoked.

14 Nov 2005

Mayo Clinic provides new strategy for designing better treatments for juvenile dermatomyositis

Mayo Clinic researchers, working with colleagues at the University of Minnesota and University of Pittsburgh, are the first to describe a new role for a specialized cell of the immune system in children suffering from a rare muscle-damaging disease known as juvenile dermatomyositis (JDM).

14 Nov 2005